<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39435656</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>Immune exhaustion in ME/CFS and long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e183810</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.183810</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are debilitating multisystemic conditions sharing similarities in immune dysregulation and cellular signaling pathways contributing to the pathophysiology. In this study, immune exhaustion gene expression was investigated in participants with ME/CFS or long COVID concurrently. RNA was extracted from peripheral blood mononuclear cells isolated from participants with ME/CFS (n = 14), participants with long COVID (n = 15), and healthy controls (n = 18). Participants with ME/CFS were included according to Canadian Consensus Criteria. Participants with long COVID were eligible according to the case definition for "Post COVID-19 Condition" published by the World Health Organization. RNA was analyzed using the NanoString nCounter Immune Exhaustion gene expression panel. Differential gene expression analysis in ME/CFS revealed downregulated IFN signaling and immunoglobulin genes, and this suggested a state of immune suppression. Pathway analysis implicated dysregulated macrophage activation, cytokine production, and immunodeficiency signaling. Long COVID samples exhibited dysregulated expression of genes regarding antigen presentation, cytokine signaling, and immune activation. Differentially expressed genes were associated with antigen presentation, B cell development, macrophage activation, and cytokine signaling. This investigation elucidates the intricate role of both adaptive and innate immune dysregulation underlying ME/CFS and long COVID, emphasizing the potential importance of immune exhaustion in disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eaton-Fitch</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudd</LastName><ForeName>Penny</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Er</LastName><ForeName>Teagan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Human Sciences (Physiology), The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hool</LastName><ForeName>Livia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Human Sciences (Physiology), The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Victor Chang Cardiac Institute, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall-Gradisnik</LastName><ForeName>Sonya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095842" MajorTopicYN="N">Immune System Exhaustion</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adaptive immunity</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Innate immunity</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> SMG and NEF have a patent for the diagnosis of long COVID (Australian Patent Application No. 2022902253 in the name of Griffith University Ltd) and myalgic encephalomyelitis/chronic fatigue syndrome using ion channel dysfunction (Global Patent Application No. WO2016176726A1 in the name of Griffith University Ltd).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39435656</ArticleId><ArticleId IdType="pmc">PMC11529985</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.183810</ArticleId><ArticleId IdType="pii">183810</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sukocheva OA, et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res. 2022;40:179&#x2013;196. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne) 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S, Eaton-Fitch N. Understanding myalgic encephalomyelitis. Science. 2022;377(6611):1150&#x2013;1151. doi: 10.1126/science.abo1261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo1261</ArticleId><ArticleId IdType="pubmed">36074854</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z, et al. T-cell exhaustion in immune-mediated inflammatory diseases: new implications for immunotherapy. Front Immunol. 2022;13:977394. doi: 10.3389/fimmu.2022.977394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.977394</ArticleId><ArticleId IdType="pmc">PMC9538155</ArticleId><ArticleId IdType="pubmed">36211414</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi JS, et al. T-cell exhaustion: characteristics, causes and conversion. Immunology. 2010;129(4):474&#x2013;481. doi: 10.1111/j.1365-2567.2010.03255.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2010.03255.x</ArticleId><ArticleId IdType="pmc">PMC2842494</ArticleId><ArticleId IdType="pubmed">20201977</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623(7985):139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, et al. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Int Immunol. 2014;26(4):233&#x2013;242. doi: 10.1093/intimm/dxt068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxt068</ArticleId><ArticleId IdType="pubmed">24343819</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch N, et al. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome. Syst Rev. 2019;8(1):279. doi: 10.1186/s13643-019-1202-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-019-1202-6</ArticleId><ArticleId IdType="pmc">PMC6857215</ArticleId><ArticleId IdType="pubmed">31727160</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas NG, et al. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990;28(6):1403&#x2013;1410. doi: 10.1128/jcm.28.6.1403-1410.1990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.28.6.1403-1410.1990</ArticleId><ArticleId IdType="pmc">PMC267940</ArticleId><ArticleId IdType="pubmed">2166084</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell S, et al. Chronic fatigue syndrome and circulating cytokines: a systematic review. Brain Behav Immun. 2015;50:186&#x2013;195. doi: 10.1016/j.bbi.2015.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.07.004</ArticleId><ArticleId IdType="pubmed">26148446</ArticleId></ArticleIdList></Reference><Reference><Citation>Curriu M, et al. Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. J Transl Med. 2013;11:68. doi: 10.1186/1479-5876-11-68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-11-68</ArticleId><ArticleId IdType="pmc">PMC3614537</ArticleId><ArticleId IdType="pubmed">23514202</ArticleId></ArticleIdList></Reference><Reference><Citation>Karhan E, et al. Perturbation of effector and regulatory T cell subsets in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) [preprint]. Posted on bioRxiv December 26, 2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2019.12.23.887505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lande A, et al. Human leukocyte antigen alleles associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Sci Rep. 2020;10(1):5267. doi: 10.1038/s41598-020-62157-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62157-x</ArticleId><ArticleId IdType="pmc">PMC7093502</ArticleId><ArticleId IdType="pubmed">32210306</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner S, et al. Autoimmunity-related risk variants in PTPN22 and CTLA4 are associated with ME/CFS with infectious onset. Front Immunol. 2020;11:578. doi: 10.3389/fimmu.2020.00578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00578</ArticleId><ArticleId IdType="pmc">PMC7161310</ArticleId><ArticleId IdType="pubmed">32328064</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell A, et al. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. Psychoneuroendocrinology. 2019;100:276&#x2013;285. doi: 10.1016/j.psyneuen.2018.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2018.11.032</ArticleId><ArticleId IdType="pmc">PMC6350004</ArticleId><ArticleId IdType="pubmed">30567628</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, et al. The clinical value of cytokines in chronic fatigue syndrome. J Transl Med. 2019;17(1):213. doi: 10.1186/s12967-019-1948-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1948-6</ArticleId><ArticleId IdType="pmc">PMC6599310</ArticleId><ArticleId IdType="pubmed">31253154</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbitt M, et al. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID) BMC Neurol. 2019;19(1):207. doi: 10.1186/s12883-019-1433-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1433-0</ArticleId><ArticleId IdType="pmc">PMC6708220</ArticleId><ArticleId IdType="pubmed">31445522</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato W, et al. Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav Immun. 2021;95:245&#x2013;255. doi: 10.1016/j.bbi.2021.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.03.023</ArticleId><ArticleId IdType="pubmed">33794313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17(5):533&#x2013;535. doi: 10.1038/s41423-020-0402-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowski M, et al. Untimely TGF&#x3b2; responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600(7888):295&#x2013;301. doi: 10.1038/s41586-021-04142-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04142-6</ArticleId><ArticleId IdType="pubmed">34695836</ArticleId></ArticleIdList></Reference><Reference><Citation>Taefehshokr N, et al. Covid-19: perspectives on innate immune evasion. Front Immunol. 2020;11:580641. doi: 10.3389/fimmu.2020.580641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.580641</ArticleId><ArticleId IdType="pmc">PMC7554241</ArticleId><ArticleId IdType="pubmed">33101306</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge R, et al. Inflammatory proteins are altered in chronic fatigue syndrome-a systematic review and meta-analysis. Neurosci Biobehav Rev. 2019;107:69&#x2013;83. doi: 10.1016/j.neubiorev.2019.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2019.08.011</ArticleId><ArticleId IdType="pubmed">31465778</ArticleId></ArticleIdList></Reference><Reference><Citation>Raanes EFW, Stiles TC. Associations between psychological and immunological variables in chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review. Front Psychiatry. 2021;12:716320. doi: 10.3389/fpsyt.2021.716320.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.716320</ArticleId><ArticleId IdType="pmc">PMC8650213</ArticleId><ArticleId IdType="pubmed">34887782</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, et al. A review of cytokine-based pathophysiology of long COVID symptoms. Front Med (Lausanne) 2023;10:1011936. doi: 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3(6):100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobcakova A, et al. Immune profile in patients with COVID-19: lymphocytes exhaustion markers in relationship to clinical outcome. Front Cell Infect Microbiol. 2021;11:646688. doi: 10.3389/fcimb.2021.646688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.646688</ArticleId><ArticleId IdType="pmc">PMC8082075</ArticleId><ArticleId IdType="pubmed">33937096</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020;11(1):3410. doi: 10.1038/s41467-020-17240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17240-2</ArticleId><ArticleId IdType="pmc">PMC7343781</ArticleId><ArticleId IdType="pubmed">32641700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzmaurice K, et al. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection. Gut. 2015;64(5):813&#x2013;819. doi: 10.1136/gutjnl-2013-306287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2013-306287</ArticleId><ArticleId IdType="pmc">PMC4392199</ArticleId><ArticleId IdType="pubmed">24996883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocal S, et al. Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients. Saudi J Gastroenterol. 2014;20(3):175&#x2013;181. doi: 10.4103/1319-3767.133007.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1319-3767.133007</ArticleId><ArticleId IdType="pmc">PMC4067914</ArticleId><ArticleId IdType="pubmed">24976281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai B, et al. Characterization of lung bronchoalveolar humoral immunity in patients with COVID-19. Emed Res. 2020;2:100009.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxelius V-A, Pandey JP. Human immunoglobulin constant heavy G chain (IGHG) (Fc&#x3b3;) (GM) genes, defining innate variants of IgG molecules and B cells, have impact on disease and therapy. Clin Immunol. 2013;149(3):475&#x2013;486. doi: 10.1016/j.clim.2013.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2013.10.003</ArticleId><ArticleId IdType="pubmed">24239836</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe5;gstr&#xf6;m P, et al. Fatigue is common in immunoglobulin G subclass deficiency and correlates with inflammatory response and need for immunoglobulin replacement therapy. Front Immunol. 2021;12:797336. doi: 10.3389/fimmu.2021.797336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.797336</ArticleId><ArticleId IdType="pmc">PMC8785394</ArticleId><ArticleId IdType="pubmed">35082787</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko A, et al. Dysregulation of protein kinase gene expression in NK cells from chronic fatigue syndrome/myalgic encephalomyelitis patients. Gene Regul Syst Bio. 2016;10:85&#x2013;93. doi: 10.4137/GRSB.S40036.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/GRSB.S40036</ArticleId><ArticleId IdType="pmc">PMC5003121</ArticleId><ArticleId IdType="pubmed">27594784</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth TK, et al. Killer cell immunoglobulin-like receptor genotype and haplotype investigation of natural killer cells from an australian population of chronic fatigue syndrome/myalgic encephalomyelitis patients. Gene Regul Syst Bio. 2016;10:43&#x2013;49. doi: 10.4137/GRSB.S39861.</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/GRSB.S39861</ArticleId><ArticleId IdType="pmc">PMC4913894</ArticleId><ArticleId IdType="pubmed">27346947</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate WP, et al. Towards a better understanding of the complexities of myalgic encephalomyelitis/chronic fatigue syndrome and long COVID. Int J Mol Sci. 2023;24(6):5124. doi: 10.3390/ijms24065124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065124</ArticleId><ArticleId IdType="pmc">PMC10048882</ArticleId><ArticleId IdType="pubmed">36982194</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksoud R, et al. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2021;19(1):81. doi: 10.1186/s12967-021-02742-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02742-4</ArticleId><ArticleId IdType="pmc">PMC7890871</ArticleId><ArticleId IdType="pubmed">33596913</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S, et al. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009;2(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680051</ArticleId><ArticleId IdType="pubmed">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed RN, et al. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19) Cell Commun Signal. 2022;20(1):79. doi: 10.1186/s12964-022-00856-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-022-00856-w</ArticleId><ArticleId IdType="pmc">PMC9162381</ArticleId><ArticleId IdType="pubmed">35655192</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaqinuddin A, Kashir J. Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using monalizumab, cholroquine, and antiviral agents. Med Hypotheses. 2020;140:109777. doi: 10.1016/j.mehy.2020.109777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109777</ArticleId><ArticleId IdType="pmc">PMC7194824</ArticleId><ArticleId IdType="pubmed">32344314</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann M, et al. Analysis of co-inhibitory receptor expression in COVID-19 infection compared to acute Plasmodium falciparum malaria: LAG-3 and TIM-3 correlate with T cell activation and course of disease. Front Immunol. 2020;11:1870. doi: 10.3389/fimmu.2020.01870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01870</ArticleId><ArticleId IdType="pmc">PMC7479337</ArticleId><ArticleId IdType="pubmed">32983106</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, John Wherry E. T cell responses in patients with COVID-19. Nat Rev Immunol. 2020;20(9):529&#x2013;536. doi: 10.1038/s41577-020-0402-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0402-6</ArticleId><ArticleId IdType="pmc">PMC7389156</ArticleId><ArticleId IdType="pubmed">32728222</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil A, et al. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series. Brain Behav Immun Health. 2024;36:100720. doi: 10.1016/j.bbih.2023.100720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100720</ArticleId><ArticleId IdType="pmc">PMC10847863</ArticleId><ArticleId IdType="pubmed">38327880</ArticleId></ArticleIdList></Reference><Reference><Citation>Sep&#xfa;lveda N, et al. Myalgic encephalomyelitis/chronic fatigue syndrome as a hyper-regulated immune system driven by an interplay between regulatory T cells and chronic human herpesvirus infections. Front Immunol. 2019;10:2684. doi: 10.3389/fimmu.2019.02684.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02684</ArticleId><ArticleId IdType="pmc">PMC6883905</ArticleId><ArticleId IdType="pubmed">31824487</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas JL, et al. Association of T and NK cell phenotype with the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front Immunol. 2018;9:1028. doi: 10.3389/fimmu.2018.01028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01028</ArticleId><ArticleId IdType="pmc">PMC5954087</ArticleId><ArticleId IdType="pubmed">29867995</ArticleId></ArticleIdList></Reference><Reference><Citation>Galan M, et al. Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers. Front Immunol. 2022;13:848886. doi: 10.3389/fimmu.2022.848886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa D, et al. Activation of cytotoxic lymphocytes and presence of regulatory T cells in the trachea of non-vaccinated and vaccinated chickens as a recall to an infectious laryngotracheitis virus (ILTV) challenge. Vaccines (Basel) 2021;9(8):865. doi: 10.3390/vaccines9080865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9080865</ArticleId><ArticleId IdType="pmc">PMC8402403</ArticleId><ArticleId IdType="pubmed">34451989</ArticleId></ArticleIdList></Reference><Reference><Citation>Penaloza-MacMaster P. CD8 T-cell regulation by T regulatory cells and the programmed cell death protein 1 pathway. Immunology. 2017;151(2):146&#x2013;153. doi: 10.1111/imm.12739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12739</ArticleId><ArticleId IdType="pmc">PMC5418463</ArticleId><ArticleId IdType="pubmed">28375543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan M, et al. Regulatory T cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID. Vaccines (Basel) 2023;11(3):699. doi: 10.3390/vaccines11030699.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030699</ArticleId><ArticleId IdType="pmc">PMC10059134</ArticleId><ArticleId IdType="pubmed">36992283</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston SC, et al. Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients. Clin Epidemiol. 2016;8:97&#x2013;107. doi: 10.2147/CLEP.S96797.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S96797</ArticleId><ArticleId IdType="pmc">PMC4878662</ArticleId><ArticleId IdType="pubmed">27279748</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome. 2003;11(1):7&#x2013;15. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda SK, Ravindran B. In vitro tumorsphere formation assays. Bio Protoc. 2013;3(3):e323. doi: 10.21769/BioProtoc.322.</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.322</ArticleId><ArticleId IdType="pmc">PMC4972326</ArticleId><ArticleId IdType="pubmed">27500184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>